Bill Would Require Device Sponsors To Stratify PMA Trial Data By Gender
This article was originally published in The Gray Sheet
Executive Summary
Cardiovascular device manufacturers would be required to stratify clinical trial information for PMA submissions by gender, race and ethnicity under the "HEART for Women Act" (S 2278)
You may also be interested in...
ADVANCENT National Registry Reveals Gender Gap In ICD Therapy
The ongoing ADVANCENT national heart failure registry reveals that men indicated for an ICD are almost twice as likely to receive the device as women
Carotid Artery Disease Screening Should Make AHRQ Research List – Guidant
Guidant is requesting the Agency for Healthcare Research & Quality to assign the study of female cardiovascular care quality to a list of CMS research priorities to be generated under the Medicare Modernization Act
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.